NEW YORK (GenomeWeb News) – Bayer Schering Pharma will used Roche’s xCELLigence System for real-time non-labeled cell analysis, Roche Applied Science said today.
Roche said Bayer is one of the first users of the recently introduced xCELLigence System, which is designed for a variety of applications including short-term kinetic analysis and assays for cell proliferation and cytotoxicity. Manfred Baier, head of Roche Applied Science, said that the firm expects pharma research to be a primary application area for the new system.
According to Roche, the system can perform label-free analysis of a 96-well plate in less than 15 seconds.
Further details of the agreement with Bayer were not disclosed.